Colistin use in pediatric intensive care unit for severe nosocomial infections: Experience of an university hospital

Annals of Clinical Microbiology and Antimicrobials

Volumn 12, Issue 1, 2013, Pages

  Karli, Arzu ^a   Paksu, Muhammet S ^a   Karadag, Adil ^a   Belet, Nursen ^a   Paksu, Sule ^a   Guney, Akif K ^b   Akgun, Muhammet ^a   Yener, Nazik ^a   Sensoy, Sema G ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

Author keywords

Child; Colistin; Multi drug resistant bacteria; Nephrotoxicity; Nosocomial infection

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; CARBAPENEM DERIVATIVE; COLISTIN; GENTAMICIN; GLYCOPEPTIDE; MEROPENEM;

ACUTE KIDNEY FAILURE; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ATAXIA TELANGIECTASIA; BLOODSTREAM INFECTION; CATHETER INFECTION; CAUSE OF DEATH; CHILD; CHILD DEATH; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFANT; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NON OLIGURIC RENAL FAILURE; OLIGURIA; PEDIATRIC HOSPITAL; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PSEUDOMONAS INFECTION; SCHOOL CHILD; SEIZURE; SEPSIS; SEPTIC SHOCK; SHUNT INFECTION; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA; VISUAL DISORDER;

ACUTE KIDNEY INJURY; ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COLISTIN; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; TREATMENT OUTCOME;

EID: 84887329459     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-12-32     Document Type: Article

References (32)

1. Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infe 2006, 12(12):1227-1230.
2. Tamma PD, Lee CK. Use of colistin in children. Pediatr infect Dis J 2009, 28(6):534-535.
3. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin infect Dis 2008, 46(7):1121-1122. author reply 1122.
4. Goverman J, Weber JM, Keaney TJ, Sheridan RL. Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J Burn Care Res 2007, 28(3):421-426.
5. Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008, 52(3):813-821.
6. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008, 13(47).
7. Ramasubban S, Majumdar A, Das PS. Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock. Ind J Crit Care Med 2008, 12(4):153-157.
8. Celebi S, Hacimustafaoglu M, Koksal N, Ozkan H, Cetinkaya M. Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients. Pediatr Int 2010, 52(3):410-414.
9. Falagas ME, Vouloumanou EK, Rafailidis PI. Systemic colistin use in children without cystic fibrosis: a systematic review of the literature. Int J Antimicrob Agents 2009, 33(6):503. e501-503 e513.
10. Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V, Tsivitanidou M, Roilides E. Colistin administration to pediatric and neonatal patients. Eur J Pediatr 2010, 169(7):867-874.
11. Rosanova M, Epelbaum C, Noman A, Villasboas M, Alvarez V, Berberian G, Sberna N, Mudryck G, Lede R. Use of colistin in a pediatric burn unit in Argentina. J Burn Care Res 2009, 30(4):612-615.
12. Paksu MS, Paksu S, Karadag A, Sensoy G, Asilioglu N, Yildizdas D, Akyildiz BN, Kendirli T, Demirkol D, Akgun M, et al. Old agent, new experience: colistin use in the paediatric Intensive Care Unit-a multicentre study. Int J Antimicrob Agents 2012, 40(2):140-144.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J infect Control 1988, 16(3):128-140.
14. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6(1):2-8.
15. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001, 29(4 Suppl):N64-N68.
16. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005, 40(9):1333-1341.
17. Jajoo M, Kumar V, Jain M, Kumari S, Manchanda V. Intravenous colistin administration in neonates. Pediatr Infect Dis J 2011, 30(3):218-221.
18. Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis. Pediatr Infect Dis J 2009, 28(2):123-127.
19. Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int JAntimicrob Agents 2010, 35(3):297-300.
20. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003, 7(5):R78-R83.
21. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005, 11(2):115-121.
22. Olesen S, Madsen PO. Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp 1967, 9(6):283-287.
23. Pintado V, San Miguel LG, Grill F, Mejia B, Cobo J, Fortun J, Martin-Davila P, Moreno S. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. J Infect 2008, 56(3):185-190.
24. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev 2008, 21(3):449-465.
25. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006, 6(9):589-601.
26. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006, 10(1):R27.
27. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin infect Dis 1999, 28(5):1008-1011.
28. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006, 27(3):224-228.
29. Gupta S, Govil D, Kakar PN, Prakash O, Arora D, Das S, Govil P, Malhotra A. Colistin and polymyxin B: a re-emergence. Ind J Crit Care Med 2009, 13(2):49-53.
30. Gunderson BW, Ibrahim KH, Hovde LB, Fromm TL, Reed MD, Rotschafer JC. Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2003, 47(3):905-909.
31. Giamarellos-Bourboulis EJ, Xirouchaki E, Giamarellou H. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2001, 40(3):117-120.
32. Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 2008, 14(9):816-827.